← Founder Notes
Archive

The first ai-designed drug has entered a phase iii trial

Yethikrishna ROriginal on Threads

the first ai-designed drug has entered a phase iii trial: insilico’s rentosertib started a 320-patient study for pulmonary fibrosis in august. the molecule came from the company’s generative chemistry engine, not a human hypothesis.

the field’s real test is whether the next one clears the fda.

Context

Verified date: Insilico's release dated Jul 7, 2026 says it initiated a Phase III trial of rentosertib, its TNIK inhibitor for idiopathic pulmonary fibrosis. A later release (Sep 9-10, 2026) says the first patient has been dosed in GENESIS-IPF-3, which it calls the world's first Phase III trial of a generative AI-driven drug. ClinicalTrials.gov lists it as NCT07687459, a randomized, double-blind, placebo-controlled study.

Insilico's HKEX announcement of Sep 10, 2026 says it completed first patient enrollment and dosing.

How it compares

The Phase III trial of rentosertib for pulmonary fibrosis matches. Insilico announced the start on Jul 7 and the first patient dosing on Sep 9-10, so the post's August start does not match either date. The 320-patient size was not seen in the sources read, so unsupported here, not refuted. in the excerpts read. 'First' is Insilico's own wording about its own trial. 'Whether the next one clears the FDA' is the author's opinion.

Related work

Watch next

  • Open the ClinicalTrials.gov record for the planned enrollment number.

Sources

  1. Insilico: initiates Phase III clinical trial for rentosertibinsilico.com
  2. Insilico: doses first patient in GENESIS-IPF-3insilico.com
  3. ClinicalTrials.gov: NCT07687459, rentosertib Phase 3clinicaltrials.gov

Provenance

The note above is reproduced unedited from the original post, first published on Threads on 1 October 2026 at 11:40 IST. Sources are the papers and datasets the note draws on.

View the original post
Embed this note
<iframe src="https://founder.myndlabs.tech/notes/embed/the-first-ai-designed-drug-has-entered-a-Dd8O-a4jFsk" width="480" height="420" style="border:0;max-width:100%" loading="lazy" title="The first ai-designed drug has entered a phase iii trial"></iframe>

More notes